Angiodynamics, a global medical device company founded in Queensbury, NY in 1988, is dedicated to elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine. With a focus on merging physician-centric design with patient outcome-driven solutions, Angiodynamics provides innovative and disruptive medical devices that address unmet patient needs and improve patient outcomes.
The company's portfolio includes endovascular therapies, vascular access, and oncology products such as the AlphaVac F1885 system for the treatment of pulmonary embolism, the NanoKnife 3.0 system for localized therapy options in oncology, and the Auryon system for peripheral atherectomy. Angiodynamics is committed to delivering safer, clinically relevant, and economically favorable solutions that help change lives and improve patient outcomes worldwide.
Generated from the website